Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

about

Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity.Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology

P2860

Q54966511-E17F04A9-1EE8-44BE-9C83-A078DCEA830C Q55428812-11EA1F25-AB01-433C-B551-817FB9B280F0 Q58695249-BC8CB740-88CF-4B1D-9DE2-92C135F5D79E

P2860

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

Item

http://www.wikidata.org/entity/Q52726999

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

@en

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

@nl

type

Item

label

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

@en

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

@nl

prefLabel

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

@en

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

@nl

P1476

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

@en

P2093

Anna Passarelli

http://www.w3.org/2001/XMLSchema#string

Francesco Silvestris

http://www.w3.org/2001/XMLSchema#string

Gabriele Madonna

http://www.w3.org/2001/XMLSchema#string

Marco Tucci

http://www.w3.org/2001/XMLSchema#string

Marilena Capone

http://www.w3.org/2001/XMLSchema#string

Patrizia Lopalco

http://www.w3.org/2001/XMLSchema#string

P2860

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Isolation and characterization of exosomes from cell culture supernatants and biological fluids

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

Nivolumab in previously untreated melanoma without BRAF mutation

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients.

P304

e1387706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2017.1387706

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Antonio Ascierto

Francesco Mannavola

Luigia Stefania Stucci

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29308314

http://www.w3.org/2001/XMLSchema#string

P932

5749659

http://www.w3.org/2001/XMLSchema#string

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

about

P2860

P2860

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932